FSH could potentially inhibit the adipogenesis signaling pathway and prevent hepatic steatosis by binding to FSHR on liver cells and downregulating the classic cAMP/PKA/CREB pathway or CREB pathway. Here, FSHR is linked to Hepatic steatosis.